Post-IPO Equity - Knight Therapeutics
Investment Firm
Overview
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing.
Announced Date
Mar 22, 2022
Funding Type
Post Ipo Equity
Highlights
Location
North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Knight Therapeutics raised $627354 on 2022-03-22 in Post-IPO Equity
Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 21, 2021 |  Secondary Market - Knight Therapeutics | - | undefined | |
| Mar 22, 2022 | Post-IPO Equity - Knight Therapeutics | 1 | - | 627.4K |
| Dec 23, 2022 | Post-IPO Debt - Knight Therapeutics | 1 | - | 38.5M |
| Apr 10, 2014 | Post-IPO Equity - Knight Therapeutics | 1 | - | 164.8M |
Recent Activity
There is no recent news or activity for this profile.